Burkitt's lymphoma recurrent

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase I/II: 1 Phase I: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase I/II

1 trial
  • Prinses Maxima Centrum voor Kinderoncologie B.V. Academic
    MB-HUCART19.1
    2023-507597-40-00 1 country n=18
    Pending

Phase I

1 trial
  • Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer Academic
    IMP not specified
    2023-507213-97-00 1 country 2024 n=52
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer Academic 1 Phase I 1
Prinses Maxima Centrum voor Kinderoncologie B.V. Academic 1 Phase I/II 0
New trials by year
2024
1
← All indication landscapes